Franklin M. Berger
Franklin M. Berger CFA is a member of the board of directors of VaxGen.
Franklin Berger is a "widely recognized biotechnology industry analyst with more than 25 years of investment experience. Most recently, he served as Managing Director, Equity Research and Senior Biotechnology Analyst at J.P. Morgan Securities, Inc. Prior to joining J.P. Morgan, Berger was Director, Equity Research and Senior Biotechnology Analyst at Salomon Smith Barney. Prior to his work as a biotechnology analyst, he managed Pantagruel Partners, which developed early-stage pharmaceutical compounds for sale to drug companies and venture capital firms. Berger holds an M.B.A. from the Harvard Graduate School of Business Administration, a M.A. in International Economics and a B.A. in International Relations both from Johns Hopkins University."
Source: VaxGen profiles.